David J Yvars Group Neuronetics, Inc. Transaction History
David J Yvars Group
- $127 Million
- Q1 2025
A detailed history of David J Yvars Group transactions in Neuronetics, Inc. stock. As of the latest transaction made, David J Yvars Group holds 24,500 shares of STIM stock, worth $105,594. This represents 0.07% of its overall portfolio holdings.
Number of Shares
24,500
Previous 46,325
47.11%
Holding current value
$105,594
Previous $69,000
30.43%
% of portfolio
0.07%
Previous 0.04%
Shares
18 transactions
Others Institutions Holding STIM
# of Institutions
54Shares Held
10.2MCall Options Held
24.1KPut Options Held
200-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$7.49 Million1.44% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.5MShares$6.46 Million0.08% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.48MShares$6.39 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$5.52 Million0.0% of portfolio
-
Four World Capital Management LLC New York, NY858KShares$3.7 Million0.69% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $116M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...